FDA Approved: * April 27, 2017 Pharm Company: *PAR PHARM INC Category:Anticonvulsant
Vigabatrin, brand name Sabril, is a medication used to treat epilepsy. It became available as a generic medication in 2019.[1]
It works by inhibiting the breakdown of γ-aminobutyric acid (GABA). It is also known as γ-vinyl-GABA, and is a structural analogue of GABA, but does not bind to GABA receptors.[2]
Contents
1 Medical uses
1.1 Epilepsy
1.2 Others
2 Adverse effects
2.1 Central nervous system
2.2 Gastrointestinal
2.3 Body as a whole
2.4 Tera...
[wikipedia]
* May have multiple approval dates, manufacturers, or labelers. 2 Discussions